Testosterone Therapy Lawsuits

defective-drugs-medical-devices-page

New links reported between Testosterone Therapy and cardiovascular disease.

The following products may be dangerous for users:

AndroGel, Androderm, Axiron, Bio-T-Gel, Delatestryl, Depo-Testosterone, Fortesta, Striant, Testim, Testopel.

Millions of men in America have been put on testosterone therapy (TT) to combat a lagging libido or general loss of energy. But that increased verve could come at a deadly cost.

Popular low-T therapy options may be doing more harm than good, as testosterone drugs have now been tied to the occurrence of heart attacks and strokes.

On January 31, 2014, the U.S. Food and Drug Administration released a safety alert warning consumers of possible risks associated with testosterone therapy. The FDA Announced that it would investigate the risk of heart attack, stroke and death in men using prescription testosterone drugs.

NPR reports that new research demonstrates that widely used testosterone drugs have been linked to an increased risk of heart attack. Researchers have shown that within 90 days of filling an initial testosterone therapy prescription, men 65 and older increased their risk of myocardial infarction by two-fold.

In one recent study of more than 55,000 men, it was found that using testosterone doubled the risk of heart attack in users older than 65.

In 2010, a small trial of testosterone gel on muscle function in men 65 or older was discontinued after an increased number of cardiovascular adverse events was noted in participants.

Now at least three independent studies have raised concerns that testosterone therapy could be linked to cardiovascular problems in older men, and in younger men with pre-existing heart conditions.

According to the New York Times the new research is prompting experts to call for more extensive warning labels on TT drugs.

Still, even with the FDA investigation and multiple studies outlining the dangers, testosterone drugs carry no mention of an increased risk for heart attack or stroke on their labels or advertising materials.

Sales of testosterone gels, patches, injections and pills have soared in recent years. In fact, with aggressive advertising campaigns, many in the medical community fear that TT drugs are being over-prescribed, even to men who have normal levels of testosterone.

At Owen, Patterson & Owen, we are investigating potential lawsuits on behalf of men who used testosterone therapies and suffered heart attacks, strokes or other serious medical conditions.

We believe that the manufacturers of these drugs must be held accountable for the risks associated with testosterone therapy. They have a responsibility to compensate families that were harmed by their failure to provide any warning about the risk of heart attack or stroke on product labels or advertising materials.

If you or a loved one has suffered a heart attack, stroke or other serious side effect while on testosterone therapy, you should consult with Owen, Patterson & Owen to determine if you are eligible to file a claim. Call our office at 800-676-5295 or complete our contact form for a complimentary consultation.

The consultation is free, and we can quickly determine if you are a candidate for legal action against the company. Call us at 800-676-5295 or send us an e-mail.

We know that our efforts on behalf of testosterone therapy patients and their families cannot take away the pain and suffering that they have experienced. But together we can help hold testosterone drug manufacturers accountable for releasing dangerous products into the marketplace without warning. We will fight for the compensation that TT patients deserve.